Identifying patients with Crohn's disease at high risk of primary nonresponse to infliximab using a radiomic‐clinical model

医学 队列 英夫利昔单抗 内科学 接收机工作特性 回顾性队列研究 克罗恩病 临床实习 曲线下面积 疾病 胃肠病学 物理疗法
作者
Xuehua Li,Yingkui Zhong,Chenglang Yuan,Jinjiang Lin,Xiaodi Shen,Minyi Guo,Baolan Lu,Jixin Meng,Yangdi Wang,Naiwen Zhang,Zixin Luo,Guimeng Hu,Ren Mao,Minhu Chen,Canhui Sun,Ziping Li,Qinghua Cao,Baili Chen,Zhihui Chen,Bingsheng Huang,Shi‐Ting Feng
出处
期刊:International Journal of Intelligent Systems [Wiley]
卷期号:37 (12): 11853-11870 被引量:2
标识
DOI:10.1002/int.23066
摘要

Approximately 13%–40% of patients with Crohn's disease (CD) show a primary loss of response to infliximab (IFX) therapy. Therefore, differentiating potential responders from primary nonresponders is clinically important. In this double-center study, we developed and validated a computed tomography enterography (CTE)-based radiomic signature (RS) for identification of CD patients at high risk of primary nonresponse (PNR) to IFX therapy, and demonstrated its incremental value to the clinical model. A total of 244 patients (training cohort, n = 119; test cohort 1, n = 51; test cohort 2, n = 74) were retrospectively recruited. Their clinical data and pretreatment CTE were retrieved and analyzed. All patients underwent IFX induction therapy. Reliability of clinical factors and radiomic-based features were assessed with the area under the receiver operating characteristic curve (AUC). In all, 1130 radiomic features were extracted from the whole inflamed gut in CTE images. In training cohort and test cohorts 1 and 2, the RS that discriminated PNR to IFX therapy yielded AUCs of 0.848, 0.789, and 0.789, respectively (all p < 0.05). By combining the clinical predictors (C-reactive protein, albumin, and body mass index) and RS, the radiomic-clinical model showed an increase in predicting performance (AUCs: 0.864, 0.794, and 0.791, respectively; all p < 0.05). Decision curve analysis and net reclassification improvement demonstrated the clinical usefulness of the radiomic-clinical model. In this study, the proposed RS showed potential as a clinical aid for the accurate identification of CD patients at high risk of PNR to IFX therapy before treatment. A combination of the RS and existing clinical factors might enable a step forward precise medicine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zwk发布了新的文献求助10
刚刚
Rondab应助李龙章采纳,获得10
刚刚
大个应助樱桃汽水怪兽采纳,获得10
2秒前
2秒前
2秒前
完美世界应助vicky采纳,获得30
2秒前
林月完成签到,获得积分10
2秒前
3秒前
PYF应助故意的鸿涛采纳,获得10
3秒前
123123完成签到,获得积分10
4秒前
Lucifer发布了新的文献求助10
5秒前
5秒前
7秒前
ZZY发布了新的文献求助10
7秒前
raincloud完成签到,获得积分10
7秒前
8秒前
内向寒云发布了新的文献求助10
9秒前
nanjiren发布了新的文献求助10
9秒前
9秒前
英俊的铭应助ee采纳,获得10
10秒前
10秒前
丰D完成签到,获得积分10
10秒前
充电宝应助无梦为安采纳,获得10
10秒前
赘婿应助知性的紫寒采纳,获得10
11秒前
11秒前
sci_porn完成签到,获得积分20
12秒前
彭于晏应助ttlash采纳,获得10
12秒前
lllllljmjmjm完成签到,获得积分10
13秒前
科研通AI2S应助jing采纳,获得10
13秒前
14秒前
风趣飞柏完成签到,获得积分20
14秒前
zhjeddie完成签到 ,获得积分10
14秒前
cj发布了新的文献求助10
14秒前
14秒前
15秒前
故意的鸿涛完成签到,获得积分10
15秒前
橙子fy16_完成签到,获得积分10
15秒前
15秒前
醉清风完成签到 ,获得积分10
16秒前
16秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974797
求助须知:如何正确求助?哪些是违规求助? 3519250
关于积分的说明 11197623
捐赠科研通 3255405
什么是DOI,文献DOI怎么找? 1797769
邀请新用户注册赠送积分活动 877156
科研通“疑难数据库(出版商)”最低求助积分说明 806202